Cancer Cell Metabolism: Implications for X-ray and Particle Radiation Therapy. International journal of particle therapy. 2019; 5:40-48.
.Limited detection of human polyomaviruses in Fanconi anemia related squamous cell carcinoma. PLoS ONE. 2018; 13.
.Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells. Clinical Cancer Research. 2018; 24:2700-2709.
.Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence. PLoS Genetics. 2018; 14.
.Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know. Viruses. 2018; 10.
.The nuclear DEK interactome supports multi-functionality. Proteins: Structure, Function and Genetics. 2018; 86:88-97.
.Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis. PLoS ONE. 2017; 12.
.DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma. Oncotarget. 2017; 8:23414-23426.
.DEK is required for homologous recombination repair of DNA breaks. Scientific Reports. 2017; 7.
.Overcoming Pluripotent Stem Cell Dependence on the Repair of Endogenous DNA Damage. Stem Cell Reports. 2016; 6:44-54.
.Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resource. International Journal of Cancer. 2023.
.Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer. Nature. 2022; 612:495-502.
.BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia. Scientific Reports. 2022; 12.
.NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival. PLoS ONE. 2022; 17.
.Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia. Cancers. 2022; 14.
.Detection of cytogenetic changes and chromosomal aneuploidy with fluorescent in situ hybridization in cytological specimens of oral cancers in Fanconi anemia-Proof of concept. Clinical and Experimental Dental Research. 2022; 8:108-116.
.Directed differentiation of human pluripotent stem cells into epidermal stem and progenitor cells. Molecular Biology Reports. 2021; 48:6213-6222.
.HPV Strain Predicts Severity of Juvenile-Onset Recurrent Respiratory Papillomatosis with Implications for Disease Screening. Cancers. 2021; 13.
.Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia. Cancers. 2021; 13.
.Inherited DNA Repair Defects Disrupt the Structure and Function of Human Skin. Cell Stem Cell. 2021; 28:424-435.e6.
.FLASH Proton Pencil Beam Scanning Irradiation Minimizes Radiation-Induced Leg Contracture and Skin Toxicity in Mice. Cancers. 2021; 13.
.Differential transcriptome response to proton versus X-ray radiation reveals novel candidate targets for combinatorial PT therapy in lymphoma. Radiotherapy and Oncology. 2021; 155:293-303.
.Tryptophan metabolism is dysregulated in individuals with Fanconi anemia. Blood Advances. 2021; 5:250-261.
.Patient-Derived Organotypic Epithelial Rafts Model Phenotypes in Juvenile-Onset Recurrent Respiratory Papillomatosis. Viruses. 2021; 13.
.An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation. Blood Advances. 2020; 4:4679-4692.
.2020; 6:45-491.
. Proceedings to the 58th Annual Conference of the Particle Therapy Cooperative Group (PTCOG58) 10–15 June 2019. International journal of particle therapy. .Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass. Oral Oncology Extra. 2019; 98:53-61.
.Cancer Cell Metabolism: Implications for X-ray and Particle Radiation Therapy. International journal of particle therapy. 2019; 5:40-48.
.The distribution of novel biomarkers in carcinoma-in-situ, microinvasive, and squamous cell carcinoma of the uterine cervix. Annals of Diagnostic Pathology. 2019; 38:115-122.
.
Mailing Address:
3333 Burnet Ave.
MLC 7015
Cincinnati, OH 45229-3039
Phone (S. Wells): 513-636-5986
Phone (Laboratory): 513-636-5967
Fax: 513-636-2880